Who Supplies Lisinopril? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Lisinopril exports, with 221+ registered manufacturers shipping to buyers across 94+ countries — yet a handful of companies dominate the shipments. MYLAN LABORATORIES LIMITED holds the largest share at 42.1% (export value: $25.5M). Close behind, LUPIN LIMITED (23.1%, $13.9M). MACLEODS PHARMACEUTICALS LTD (3.1%, $1.9M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Lisinopril? Top Manufacturers & Their Buyers
Flow of Lisinopril from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Lisinopril Supplier Network — Key Market Intelligence
The Lisinopril export market from India is led by MYLAN LABORATORIES LIMITED, which alone commands a 42.1% share, shipping $25.5M worth of product across 16 shipments. The second-largest exporter, LUPIN LIMITED, contributes $13.9M (23.1%) to the overall market. Combined, the top two suppliers alone account for 65.2% of all Lisinopril exports, indicating a relatively concentrated supply base.
Across all 221 tracked manufacturers, the total Lisinopril export value stands at $60.4M from 3.5K shipments. The market average shipment value is $17.2K. The single largest buyer relationship in terms of trade value is MYLAN B,V,, receiving $19.6M worth of product.
The combined buyer network spans 14 named purchasing companies, including MYLAN B,V,, MYLAN IRELAND C/O ALLOGA RDC,, MYLAN B,V C/0 TJOAPA, LUPIN PHARMACEUTICALS INC, XXPINXXHARXXCEUXXCALXXINC and 9 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the first-largest Lisinopril exporter from India, with a market share of 42.1% and a total export value of $25.5M across 16 shipments. Their average shipment value of $1.6M is above the market average of $17.2K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. MYLAN B,V, is the dominant customer, accounting for 76.8% of this supplier's tracked business. Top customers include:
• MYLAN B,V, — $19.6M across 12 shipments (76.8% of this supplier's total exports)
• MYLAN IRELAND C/O ALLOGA RDC, — $5.0M across 3 shipments (19.6% of this supplier's total exports)
• MYLAN B,V C/0 TJOAPA — $898.1K across 1 shipments (3.5% of this supplier's total exports)
• MYLAN IRELAND C/O ALLOGA RDC, — $11.4K across 0 shipments (0.0% of this supplier's total exports)
• MYLAN B,V, — $8.5K across 0 shipments (0.0% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $1.6M is 9155% above the market average of $17.2K, consistent with large-order contracts or value-added formulations.
2LUPIN LIMITED
LUPIN LIMITED is the second-largest Lisinopril exporter from India, with a market share of 23.1% and a total export value of $13.9M across 86 shipments. Their average shipment value of $162.2K is above the market average of $17.2K, suggesting premium or bulk contract pricing.
LUPIN LIMITED serves 5 named buyers in our database. LUPIN PHARMACEUTICALS INC is the dominant customer, accounting for 57.0% of this supplier's tracked business. Top customers include:
• LUPIN PHARMACEUTICALS INC — $7.9M across 49 shipments (57.0% of this supplier's total exports)
• XXPINXXHARXXCEUXXCALXXINC — $4.2M across 26 shipments (30.1% of this supplier's total exports)
• XXALLXXT PXXRMAXXUTIXXLS XXALTXXLLCX — $828.0K across 5 shipments (5.9% of this supplier's total exports)
• LUPIN PHARMACEUTICALS INC — $656.7K across 4 shipments (4.7% of this supplier's total exports)
• XXPINXXHARXXCEUXXCALXXINC — $315.0K across 2 shipments (2.3% of this supplier's total exports)
Key Insight: LUPIN LIMITED's per-shipment value of $162.2K is 843% above the market average of $17.2K, consistent with large-order contracts or value-added formulations.
3MACLEODS PHARMACEUTICALS LTD
MACLEODS PHARMACEUTICALS LTD is the third-largest Lisinopril exporter from India, with a market share of 3.1% and a total export value of $1.9M across 3 shipments. Their average shipment value of $631.5K is above the market average of $17.2K, suggesting premium or bulk contract pricing.
MACLEODS PHARMACEUTICALS LTD serves 1 named buyer in our database. FORTRESS PHARMACEUTI is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• FORTRESS PHARMACEUTI — $1.9M across 3 shipments (100.0% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $631.5K is 3572% above the market average of $17.2K, consistent with large-order contracts or value-added formulations.
4STALLION LABORATORIES PRIVATE LIMITED
STALLION LABORATORIES PRIVATE LIMITED is the fourth-largest Lisinopril exporter from India, with a market share of 3.1% and a total export value of $1.9M across 6 shipments. Their average shipment value of $309.9K is above the market average of $17.2K, suggesting premium or bulk contract pricing.
STALLION LABORATORIES PRIVATE LIMITED serves 1 named buyer in our database. To The Order is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• To The Order — $1.9M across 6 shipments (100.0% of this supplier's total exports)
Key Insight: STALLION LABORATORIES PRIVATE LIMITED's per-shipment value of $309.9K is 1702% above the market average of $17.2K, consistent with large-order contracts or value-added formulations.
5IPCA LABORATORIES LIMITED
IPCA LABORATORIES LIMITED is the fifth-largest Lisinopril exporter from India, with a market share of 2.7% and a total export value of $1.6M across 418 shipments. Their average shipment value of $3.9K is below the market average of $17.2K, reflecting a high-volume, competitive pricing strategy.
IPCA LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• NA — $775.6K across 200 shipments (47.8% of this supplier's total exports)
• VITPHARMA MARKET — $289.4K across 75 shipments (17.8% of this supplier's total exports)
• TO THE ORDER — $273.8K across 71 shipments (16.9% of this supplier's total exports)
• ZYFAS PHARMA PTE LTD — $182.4K across 47 shipments (11.2% of this supplier's total exports)
• STREET AUCKLAND CENT — $101.2K across 26 shipments (6.2% of this supplier's total exports)
Key Insight: IPCA LABORATORIES LIMITED operates with high shipment frequency (418 shipments) at a per-shipment value of $3.9K, indicating a broad distribution network with many smaller, regular orders.
6MICRO LABS LIMITED
MICRO LABS LIMITED is the fifth-largest Lisinopril exporter from India, with a market share of 2.4% and a total export value of $1.4M across 50 shipments. Their average shipment value of $28.5K is above the market average of $17.2K, suggesting premium or bulk contract pricing.
MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• BROWN AND BURK UK LIMITED — $616.7K across 22 shipments (43.3% of this supplier's total exports)
• HAWKARY PHARMACEUTICAL COMPANY# — $481.2K across 17 shipments (33.8% of this supplier's total exports)
• HAWKARY PHARMACEUTICAL COMPANY# — $171.7K across 6 shipments (12.0% of this supplier's total exports)
• OOO "LIFE CELL" LTD — $93.5K across 3 shipments (6.6% of this supplier's total exports)
• DA NANG PHARMACEUTIC — $62.2K across 2 shipments (4.4% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED's per-shipment value of $28.5K is 66% above the market average of $17.2K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Lisinopril Flows
Once Lisinopril leaves the manufacturing plants of companies like MYLAN LABORATORIES LIMITED and LUPIN LIMITED, it travels to 5 destination markets with a combined import value of $60.4M. Netherlands absorbs the largest share at 42.6% ($25.8M), followed by United States (25.0%) and Nigeria (6.1%).
In Netherlands — the top destination — named importers include MYLAN B,V,, MYLAN IRELAND C/O ALLOGA RDC,. In United States, key buyers are LUPIN PHARMACEUTICAL INC, XXPINXXHARXXCEUXXCALXXINC, XXALLXXT PXXRMAXXUTIXXLS XXALTXXLLCX.
This geographic spread reflects Lisinopril's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Lisinopril Go? Top Importing Countries & Their Buyers
Trade flow of Lisinopril exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Netherlands
Netherlands ranks as the first-largest destination for Lisinopril imports from India, with a total trade value of $25.8M across 5 shipments — representing a 42.6% share of all Lisinopril exports. The average shipment value of $5.2M is above the global average of $17.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Lisinopril importers in Netherlands: MYLAN B,V, is the largest buyer, accounting for 75.9% ($19.6M) of this market's total imports.
• MYLAN B,V, — $19.6M (75.9% of Netherlands's total)
• MYLAN IRELAND C/O ALLOGA RDC, — $5.0M (19.4% of Netherlands's total)
Key Insight: Netherlands's per-shipment average of $5.2M (29874% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Netherlands is a key market for Lisinopril imports from India.
2United States
United States ranks as the second-largest destination for Lisinopril imports from India, with a total trade value of $15.1M across 64 shipments — representing a 25.0% share of all Lisinopril exports. The average shipment value of $235.7K is above the global average of $17.2K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Lisinopril importers in United States: LUPIN PHARMACEUTICAL INC is the largest buyer, accounting for 52.7% ($7.9M) of this market's total imports.
• LUPIN PHARMACEUTICAL INC — $7.9M (52.7% of United States's total)
• XXPINXXHARXXCEUXXCALXXINC — $4.2M (27.8% of United States's total)
• XXALLXXT PXXRMAXXUTIXXLS XXALTXXLLCX — $828.0K (5.5% of United States's total)
Key Insight: United States's per-shipment average of $235.7K (1271% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Lisinopril imports from India.
3Nigeria
Nigeria ranks as the third-largest destination for Lisinopril imports from India, with a total trade value of $3.7M across 0 shipments — representing a 6.1% share of all Lisinopril exports. The average shipment value of $3.7M is above the global average of $17.2K, indicating high-value procurement contracts or branded formulations.
Key Insight: Nigeria's per-shipment average of $3.7M (21371% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Nigeria is a key market for Lisinopril imports from India.
4United Kingdom
United Kingdom ranks as the fourth-largest destination for Lisinopril imports from India, with a total trade value of $2.3M across 34 shipments — representing a 3.8% share of all Lisinopril exports. The average shipment value of $67.4K is above the global average of $17.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Lisinopril importers in United Kingdom: BROWN AND BURK UK LIMITED is the largest buyer, accounting for 37.2% ($852.4K) of this market's total imports.
• BROWN AND BURK UK LIMITED — $852.4K (37.2% of United Kingdom's total)
• RELONCHEM LTD — $345.8K (15.1% of United Kingdom's total)
Key Insight: United Kingdom's per-shipment average of $67.4K (292% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Kingdom is a key market for Lisinopril imports from India.
5Georgia
Georgia ranks as the fifth-largest destination for Lisinopril imports from India, with a total trade value of $2.1M across 0 shipments — representing a 3.5% share of all Lisinopril exports. The average shipment value of $2.1M is above the global average of $17.2K, indicating high-value procurement contracts or branded formulations.
Key Insight: Georgia's per-shipment average of $2.1M (12146% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Georgia is a key market for Lisinopril imports from India.
People Also Ask — Lisinopril Supplier & Trade Network
Who are the top suppliers of Lisinopril from India?+
Which companies buy Lisinopril from Indian manufacturers?+
Where does Lisinopril exported from India go?+
What is the market share of the top Lisinopril supplier from India?+
What is the average shipment value for Lisinopril exports from India?+
Is Lisinopril manufactured in India and exported globally?+
Which country imports the most Lisinopril from India?+
Who are the buyers of Lisinopril in United States?+
How concentrated is the Lisinopril supplier market in India?+
How do I find verified buyers for Lisinopril in specific countries?+
Lisinopril Trade Network — Key Takeaways
- 1MYLAN LABORATORIES LIMITED is India's dominant Lisinopril exporter with a 42.1% market share and $25.5M in total exports — making it the single most important sourcing entity in this market.
- 2The top 221 suppliers collectively account for 76.5% of all tracked Lisinopril exports, with a combined trade value of $60.4M.
- 3Netherlands is the largest destination market, absorbing 42.6% of India's Lisinopril exports ($25.8M). United States (25.0%) and Nigeria (6.1%) follow.
- 4With 3.5K total shipments averaging $17.2K each, the Lisinopril export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include MYLAN B,V,, MYLAN IRELAND C/O ALLOGA RDC,, LUPIN PHARMACEUTICALS INC, XXPINXXHARXXCEUXXCALXXINC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 94 countries
Network value: $60.4M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Lisinopril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Lisinopril.
- 2.Flow Mapping: 221 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,514 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 94 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,514 Verified Shipments
221 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists